These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10465694)

  • 1. (-)-Pindolol increases dialysate concentrations of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely-moving rats.
    Millan MJ; Gobert A
    Neuropharmacology; 1999 Jun; 38(6):909-12. PubMed ID: 10465694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.
    Millan MJ; Gobert A; Rivet JM; Adhumeau-Auclair A; Cussac D; Newman-Tancredi A; Dekeyne A; Nicolas JP; Lejeune F
    Eur J Neurosci; 2000 Mar; 12(3):1079-95. PubMed ID: 10762339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats.
    Gobert A; Millan MJ
    Neuropharmacology; 1999 Feb; 38(2):315-7. PubMed ID: 10218874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat.
    Gobert A; Rivet JM; Lejeune F; Newman-Tancredi A; Adhumeau-Auclair A; Nicolas JP; Cistarelli L; Melon C; Millan MJ
    Synapse; 2000 Jun; 36(3):205-21. PubMed ID: 10819900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.
    Millan MJ; Dekeyne A; Gobert A
    Neuropharmacology; 1998 Jul; 37(7):953-5. PubMed ID: 9776391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats.
    Gobert A; Rivet JM; Cistarelli JM; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1326-9. PubMed ID: 9048781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572.
    Gobert A; Dekeyne A; Millan MJ
    Neuropharmacology; 2000 Jul; 39(9):1608-16. PubMed ID: 10854905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release.
    Gobert A; Rivet JM; Audinot V; Newman-Tancredi A; Cistarelli L; Millan MJ
    Neuroscience; 1998 May; 84(2):413-29. PubMed ID: 9539213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of beta-adrenoceptor blocker pindolol, calcium antagonist verapamil and their combination on retention in step-down- and shuttle-box-trained rats and on brain biogenic monoamines.
    Lazarova-Bakarova MB; Stancheva S; Petkova B; Genkova-Papasova M; Alova L; Boyanova E; Staneva-Stoytcheva D
    J Physiol Paris; 1997 Dec; 91(6):301-5. PubMed ID: 9457662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways.
    Millan MJ; Gobert A; Lejeune F; Dekeyne A; Newman-Tancredi A; Pasteau V; Rivet JM; Cussac D
    J Pharmacol Exp Ther; 2003 Sep; 306(3):954-64. PubMed ID: 12750432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal exposure to the beta-adrenoceptor agonist clenbuterol has regionally selective direct and long-term effects on rat brain beta-adrenoceptors and monoamine metabolism.
    Erdtsieck-Ernste EB; Feenstra MG; Botterblom M; Boer GJ
    Brain Res Dev Brain Res; 1993 Jan; 71(1):27-35. PubMed ID: 7679335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.
    Dekeyne A; Gobert A; Iob L; Cistarelli L; Melon C; Millan MJ
    Psychopharmacology (Berl); 2001 Nov; 158(2):213-8. PubMed ID: 11702096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.
    Gobert A; Billiras R; Cistarelli L; Millan MJ
    J Neurosci Methods; 2004 Dec; 140(1-2):141-52. PubMed ID: 15589344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of milnacipran and pindolol on extracellular noradrenaline and serotonin levels in guinea pig hypothalamus.
    Moret C; Briley M
    J Neurochem; 1997 Aug; 69(2):815-22. PubMed ID: 9231743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.